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Abstract
Membrane-anchored mucins are present in the apical surface glycocalyx of mucosal epithelial cells, each mucosal
epithelium having at least two of the mucins. The mucins have been ascribed barrier functions, but direct comparisons of
their functions within the same epithelium have not been done. In an epithelial cell line that expresses the membrane-
anchored mucins, MUC1 and MUC16, the mucins were independently and stably knocked down using shRNA. Barrier
functions tested included dye penetrance, bacterial adherence and invasion, transepithelial resistance, tight junction
formation, and apical surface size. Knockdown of MUC16 decreased all barrier functions tested, causing increased dye
penetrance and bacterial invasion, decreased transepithelial resistance, surprisingly, disruption of tight junctions, and
greater apical surface cell area. Knockdown of MUC1 did not decrease barrier function, in fact, barrier to dye penetrance and
bacterial invasion increased significantly. These data suggest that barrier functions of membrane-anchored mucins vary in
the context of other membrane mucins, and MUC16 provides a major barrier when present.
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Introduction
The apical glycocalyx of epithelia of mucosae lies at the
interface between the external environment and the mucosal
tissue. As such, it provides a protective barrier that prevents
pathogen adherence and internalization as well as a selective
barrier to penetrance by other compounds. Major components of
the glycocalyx are membrane-anchored mucins that are also
termed membrane-spanning, membrane-bound or membrane-
tethered mucins (Fig. 1A) (for review see [1,2,3]).
Mucins are heavily O-glycosylated glycoproteins that share the
feature of tandem repeats of amino acids within their protein
backbone, these repeats are rich in serine and threonine, providing
sites for the association of O-glycans. Two types of mucins have
been identified–secreted and membrane-anchored (MAMs). Un-
like the secreted mucins that are produced by epithelial goblet cells
and mucosal glands, MAMs lack N- and C-terminal region
cysteine-rich domains that allow homomultimerization to form
thick mucus, and have instead, a membrane-spanning domain and
a short cytoplasmic tail that tethers the mucin to the apical surface.
All wet-surfaced mucosal epithelia express MAMs including those
of the ocular surface, and respiratory, gastrointestinal and
genitourinary tracts. Mucins have been named in order of
discovery MUC 1, 2 etc., with ‘‘MUC’’ designating human genes,
and ‘‘Muc’’ mouse genes. The membrane-anchored mucins
include MUC1, MUC3A, MUC3B, MUC4, MUC12, MUC13,
MUC15, MUC16, MUC17, MUC20, and MUC21, with MUC1
being ubiquitously expressed and MUC16 the largest of the group.
The repertoire of MAMs in regions of wet-surfaced mucosae
varies. For example, MUCs 1 and 16 are expressed by epithelia of
the ocular surface, and respiratory and female reproductive tracts,
whereas MUCs 3, 12 and 13 are predominant on gut epithelial
surfaces (for review see [1,2,3,4,5]).
Several of the MAMs have been reported to be multifunctional,
having both surface barrier functions and documented signaling
functions either through their cytoplasmic tails or through EGF-
like domains located near the membrane-spanning region in the
ectodomain [2,3]. The most studied of the MAMs have been
MUCs 1, 4 and 16, particularly as each are tumor cell markers
and are highly upregulated in breast, pancreatic and ovarian
cancers, respectively (for review see [1]). As a result of their
association with cancers, the majority of studies of their functions
have been documented in cancer cell lines, whereas understanding
the functions of specific MAMs in the glycocalyx of native mucosal
surfaces has lagged. In those studies of the function of MAMs in
native epithelia that have been done, the ectodomains, particularly
of MUC1 and MUC16 (also known as the CA125 antigen), are
ascribed similar functions, that of preventing adherence/pene-
trance of pathogens and cell-cell adhesion [6,7]. A comparison of
the molecular structure and size of MUC1 and MUC16 (Fig. 1B)
demonstrates that, of the two mucins, the ectodomain of MUC16
is about 20 times larger than that of MUC1 and its ectodomain
includes a number of sea urchin sperm protein, enterokinase and
agrin (SEA) modules, whereas MUC1 has one SEA module [7].
These modules are found in many membrane-associated proteins
that are released from the cell surface [8].
As examples of MUC1’s reported role in pathogen barrier
function, adenoviral penetrance into airway tracheal bronchial
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Muc1 limited Helicobacter pylori binding to gastric epithelial cells,
and expression of MUC1 enhanced resistance to C. jejuni cytolethal
distending toxin (CDT) in vitro and in CDT null mice, C. jejuni
showed lower gastric colonization in Muc1(2/2) mice in vivo
[10]. Since the sequence and ectodomain sizes of human and
mouse MUC1 and MUC16 vary greatly (BLAST database
comparisons) and since the mucosal epithelial expression profiles
of MUC16 varies greatly between humans and mice [11], it is
difficult to draw conclusions regarding the function of human
mucin genes from Muc null mice. Thus studies of human mucin
genes have employed in vitro models, showing for example, over-
expression of MUC1 has been demonstrated to prevent E-
cadherin mediated cell-cell adhesion [12]. MUC16, the largest of
the MAMs, with an extracellular domain of approximately 22,000
amino acids, has been demonstrated to be a barrier to bacterial
adherence [13] and internalization [14] as well as to penetrance of
dyes [13,15]. MUC16 also has anti-adhesive properties in that this
MAM has been demonstrated to prevent adherence of trophoblast
cells to uterine epithelia [5].
Studies testing the roles of the MAMs in barrier function of
native epithelia have studied only one mucin per epithelium,
despite the fact that most epithelia express and place several
mucins at their apical surfaces. There is no information on the
relative roles of MAMs in barrier function within the same
epithelial glycocalyx. The purpose of the study reported herein,
was to compare the barrier functions of MUC1 and MUC16 in
the same mucosal epithelial cell type. The human corneal
epithelium has only two of the large membrane mucins in its
apical glycocalyx and thus represents an excellent model for
comparison of the barrier function of these two mucins. Results
reported here demonstrate distinct differences between MUC1
and MUC16 barrier function, ability to prevent dye penetrance
and bacterial adherence/internalization. Surprisingly, the com-
parison also demonstrated that MUC16 exhibits additional barrier
function in that it contributes to tight junction formation,
transepithelial electrical resistance (TER) and to apical epithelial
cell surface area, whereas MUC1 does not.
Materials and Methods
Ethics statement
As described previously for development and characterization of
the telomerase transformed human corneal epithelial cell line
(HCLE) used in this study [16] human corneal epithelial cells were
derived from human corneoscleral rims provided by Roger
Steinert and Ann Bajart of Ophthalmic Consultants of Boston.
For comparing amount of MUC16 antibody binding on apical
surfaces of epithelial cells in culture to that of native tissue
discarded full thickness human corneal epithelial sheets, removed
by epikeratome for corrective refractive surgery, were kindly
provided by Ula Jurkunas, MD, of the Massachusetts Eye and Ear
Infirmary. These samples were obtained without patient identifiers
as discarded tissue post surgery and the Schepens Eye Research
Institute Institutional Review Board (IRB) waived the need for
approval and consent.
Generation of stable MUC knockdown cells and cell
culture
MUC1 was stably knocked down in the previously described
telomerase transformed human corneal-limbal epithelial (HCLE)
cell line [16] by two rounds of transfection with 1 mg of the
plasmid psiRNA-H1b-MUC1 (InVivoGen) encoding a hairpin,
targeting the MUC1 gene, using Polyfect transfection reagent
(Qiagen) in the first round, followed by Effectene transfection
reagent (Qiagen) in the second round to improve the transfection
efficiency. The siMUC1 sequence used (59-ACCTCCAGTT-
TAATTCCTC-39) was previously reported to be efficient for
knockdown of MUC1 in pancreatic tumor cells [17]. Stable
transfectants were selected with 5-mg/ml blasticidin and the
resultant cell line was designated shMUC1 knockdown cells.
Control cells were similarly generated by transfection with a
plasmid containing a nonsense, scrambled siRNA (psiRNA-
hH1blasti-LUC; InVivoGen) or were non-transfected cells. These
cell lines were designated scr1 or NT cells, respectively. Stable
knockdown of MUC16 in HCLE cells using pSuperRetro-puro
Figure 1. Diagram of the distribution of the MAMs MUC1 and
MUC16 in the epithelial glycocalyx and their molecular
domains. (A) Electron micrograph showing diagrammatically, the
distribution of MUC1 (red) and MUC16 (yellow) within the electron
dense glycocalyx (top arrow) present at the tips of membrane folds or
microplicae of an epithelial cell. Note the actin filaments inserting into
the membrane at the tips of the microplicae where the cytoplasmic tails
of the membrane mucins are present (bottom arrow). (B) Both MUC1
and MUC16 have a short cytoplasmic tail, a transmembrane domain and
an extended, highly glycosylated extracellular domain that contains
tandem repeats of amino acids, rich in serine and threonine, that allow
the heavy O-glycosyation of the molecules. MUC1 has one sea urchin
sperm protein, enterokinase and agrin (SEA) module, whereas MUC16
has multiple SEA modules interspersed within tandem repeats and, in
addition, a shorter cytoplasmic tail and an ERM binding domain. Note
that the MUC16 ectodomain is approximately 20 times longer than that
of MUC1. It has been estimated that MUC16 can extend up to 250–
300 nm into the glycocalyx [43]. (Electron micrograph taken from [50]
with permission.) Scale Bar=500 nm.
doi:10.1371/journal.pone.0100393.g001
Comparison of Mucins MUC1 and MUC16 in Epithelial Barrier Function
PLOS ONE | www.plosone.org 2 June 2014 | Volume 9 | Issue 6 | e100393containing MUC16 siRNA sequence 2 (59-CTGCATCTACTCC-
CATCTC-39) was previously reported [13] and cells were
designated as shMUC16 cells. Controls were similarly generated
using nonsense, scrambled siRNA and were designated as scr16
cells.
Non-transfected (NT), scrambled shRNA transfected (scr1,
scr16) and shMUC1 or shMUC16 transfected HCLE cells were
grown in keratinocyte serum-free medium (Invitrogen) supple-
mented with 25 mg/ml bovine pituitary extract, 0.2 ng/ml
epidermal growth factor and 0.4 mM CaCl2 to confluence,
followed by DMEM/F12 plus 10% calf serum and 10 ng/ml
EGF for 7 d to achieve optimal mucin production [16]. RNA was
harvested using TRIzol reagent (Invitrogen), and protein with 2%
SDS plus protease inhibitors (Roche Diagnostics). All experiments
were performed a minimum of two times with a minimum of 3
replicates per experiment.
Quantitation of mucin protein
MUC1 and -16 proteins in cell lysates or present on the cell
surface (isolated by capture of biotinylated cell surface proteins
using the Pierce Pinpoint Cell Surface Protein Isolation Kit
(ThermoScientific) following the manufacturer’s recommenda-
tions) [18,19] were separated on 1% SDS-Agarose gels [20,21],
transferred to nitrocellulose and assayed by Western blot [22],
using antibodies 214D4 (Upstate) to MUC1 and anti-human
CA125, Clone M11 (NeoMarkers) to MUC16. Blots were
reprobed with antibody to GAPDH (Santa Cruz Biotechnology)
as a loading control. Densitometric analyses of protein bands
recognized by MUC1 or MUC16 antibodies were performed
using 1D Image Analysis Software, Version 2.02 (Eastman Kodak,
Co.). Data for total cellular MUC were expressed as MUC
normalized to GAPDH and for cell surface MUC normalized per
equivalent cm
2 of growth area and then both expressed relative to
HCLE NT cells.
Assessment of barrier function
Rose bengal dye penetrance. shMUC1, shMUC16 cell
lines, and NT, scr1, and scr16 control HCLE cell lines grown for
optimal mucin production, were rinsed with PBS and incubated
for 5 min with 0.1% solution of the anionic dye rose bengal in
Ca
2+/Mg
2+-free PBS. Dye was aspirated, 5 images per well were
immediately photographed at room temperature (RT) with a 10X
objective on a Nikon Inverted Eclipse TS100 microscope with a
Spot Insight camera (Diagnostic Instruments, Inc.), and areas
excluding the dye, representing the areas protected from dye
penetrance, were quantitated using ImageJ software (NIH) as
previously described [13,14,15].
Bacterial adherence and invasion. Epithelial cells were
grown for optimal mucin production, antibiotics were removed
from the culture medium for the last 24 h of culture, and cells were
rinsed with unsupplemented DMEM/F12 prior to addition of
bacteria. Following incubation with bacteria, the cultures were
rinsed 3 times with sterile PBS before proceeding to the assays for
adherence and invasion.
Two methods were used to assess bacterial adherence. Epithelial
cultures were A) incubated with 2610
7 colony forming units (cfu)
of FITC-labeled Staphylococcus aureus, strain ALC1435 [23], which
had been labeled for 30 min on ice with 0.1 mg/ml of FITC in
PBS, collected by centrifugation and washed 6 times with PBS
prior to re-suspension in DMEM/F12 for 1 h. The number of
adherent bacteria per microscopic field were quantitated using
Image J [13] or B) incubated with 5610
7 cfu of the Staphylococcus
aureus for 1 h, and bacteria adherent to cells were determined by
plating aliquots of serial dilutions of epithelial cells on agar plates
as previously described [24]. Bacterial invasion was assayed
following incubation with 5610
7 cfu Staphylococcus aureus for 4 h,
treatment with gentamycin and penicillin to kill extracellular
bound bacteria and plating of serial dilutions of epithelial cells
lysed with 1% saponin [14,25]. In the last two assays, the number
of recovered bacteria was expressed as a percentage of bacteria
initially added to the cultures.
Tight junction function. Tight junction function was
assayed by measuring transepithelial electrical resistance (TER)
using an EVOM
2 Epithelial Voltohmmeter (World Precision
Instruments) [26,27] in shMUC1, shMUC16 cells, as well as NT,
scr1, and scr16 control cells that were plated on 0.4-mm pore
Transwell inserts (Corning) and grown for optimal mucin
expression (7 d in serum containing medium). After subtraction
of the contribution of the filter and bathing medium, data were
expressed as Ohms*cm
2 of growth area.
Quantitative real-time PCR. Real-time RT-qPCR using
TaqMan chemistry and pre-validated primers and probes (Applied
Biosystems) were used to quantitate message levels of the epithelial
tight junction components, Zonula occludens 1 (ZO-1) and
occludin. One mg of total RNA from each cell line was reverse
transcribed using iScript cDNA Synthesis Kit (Bio-Rad). Data
were expressed relative to HCLE NT control cells after
normalization to GAPDH (endogenous control) as described
[16,28].
Immunofluorescence localization studies
Cultures grown for optimal mucin expression on Lab Tek
chamber glass slides (Nunc) were fixed in 2% paraformaldehyde in
PBS and labeled with antibodies specific for MUC1 (214D4;
Upstate) and MUC16 (M11, NeoMarkers; OC125, DAKO) as
previously described [13,29].
Tight junctions on apical cells of the cultures were localized
using modification of a previously described method [30]. Briefly,
cultures were labeled with an antibody specific for ZO-1
(Invitrogen) or occludin (Invitrogen) following fixation in ice-cold
methanol and permeabilization (ZO-1 only) with 0.02% Tween 20
in PBS. Cell surface area, expressed as pixels
2, was measured in
ZO-1 labeled images in Adobe Photoshop using the histogram
function. Images were photographed at room temperature with a
25X objective on a Zeiss Photoscope III with the FITC filter with
a Spot Insight camera.
For double label of tight junctions and the actin cytoskeleton,
cells grown on glass chambered slides were fixed for 10 min in 2%
paraformaldehyde at RT, washed with PBS, permeabilized with
1% Triton-X-100 in PBS, washed with PBS, blocked with PBS
containing 1% BSA and incubated in Rhodamine-conjugated
Phalloidin (Molecular Probes) for 1 h at RT. Cultures were then
washed in PBS, repermeabilized, washed in PBS, reblocked as
above and incubated overnight at 4uC with an antibody specific
for occludin (Invitrogen). Cultures were washed with PBS,
reblocked and incubated with FITC-conjugated anti-mouse IgG
(Jackson Immunoresearch). Following final washes in PBS, slides
were mounted with Vectashield mounting medium (Vector Labs)
and photographed at RT on a Leica TCS SP5 Confocal Laser
Scanning microscope (Leica).
For comparing amount of MUC16 antibody binding on apical
surfaces of epithelial cells in culture to that of native tissue,
discarded full-thickness human corneal epithelial sheets, removed
by epikeratome for corrective refractive surgery (kindly provided
by Ula Jurkunas, MD), were fixed in 4% paraformaldehyde, and
MUC16 was immunolocalized on the apical cell surface using
either the H185 antibody, which is specific to O-acetylated sialic
acid residues on MUC16 [31,32] or antibody CA125, Clone M11
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were measured in Photoshop using the histogram function.
Spearman Rank Correlation analyses (Instat 3 Statistical Software)
were performed for the amount of antibody binding versus cell
surface area.
Immunoelectron microscopy
Cultures grown on glass chamber slides were fixed in 2%
paraformaldehyde, rinsed in PBS, permeabilized with 0.3%
Triton-X-100 in PBS, briefly rinsed in PBS and washed at RT
with wash buffer (PBS containing 0.8% BSA and 0.1% Fish
Gelatin). Cultures were then incubated in blocking buffer (PBS
containing 0.8% BSA, 0.1% Fish Gelatin and 5% normal donkey
serum). After a brief incubation in wash buffer, cultures were
incubated overnight at 4uC in antibodies to MUC1 (214D4) or
MUC16 (Clone OC125, Dako) diluted in incubation buffer (wash
buffer plus 1% normal donkey serum). After extensive washes in
wash buffer, cultures were incubated in 10 nm gold conjugated
anti-mouse IgG (Sigma) in incubation buffer overnight at 4uC.
Specimens were washed in wash buffer followed by PBS, post-
fixed in K strength Karnovsky’s fixative, scraped off the slide in a
jelly roll fashion and processed for transmission electron micros-
copy. Thin sections were imaged at 10,400 X on a Philips 300
transmission electron microscope (Philips).
Scanning electron microscopy
Cell cultures were grown on 12 mm diameter glass coverslips,
fixed in K strength Karnovsky’s fixative, dehydrated through an
ethanol series, critical point dried with a SamDri-795 critical point
dryer (Tousimis) and coated with chromium using an Ion Beam
Coater 610 (Gatan). Samples were photographed on a JEOL
7401F Field Emission Scanning Electron Microscope (JEOL).
Statistical analyses
Statistical analyses were performed using the Mann-Whitney U
Test (for Western blots and rose bengal dye penetrance), one-way
ANOVA with Student-Newman-Keuls Multiple Comparisons
post-hoc test (for bacterial invasion), or Kruskal-Wallis test with
Dann’s Multiple Comparisons post-hoc test (for TER and apical
cell surface area) using Instat 3 statistical software or two-tailed
Student’s t-test (for bacterial adherence and qPCR) using
Microsoft Excel for Mac 2011 v. 14.3.5. Results are expressed as
mean +/2 SEM. p,0.01 was considered significant.
Results
Development of an assay to compare functions of MAMs
in an epithelial model system
A human corneal epithelial cell line was used to develop the
model system to compare the functions of MUC1 and MUC16 in
a mucosal epithelium. We have previously described the develop-
ment and characterization of the immortalized human corneal-
limbal epithelial (HCLE) cell line that differentiates to express the
MUC1 and MUC16 mucin repertoire of the native epithelium
[16]. These HCLE cells, when grown to confluence in serum-free
medium followed by culture in serum-containing medium for 7 d,
stratify to 3–5 cell layers (Fig. 2A) and have surface microplicae/
microridges typical of native apical epithelial cells with MUC1 and
MUC16 present on them (Fig. 2B, C). In addition, the pattern of
localization of the two MAMs on the apical surface of the stratified
epithelial cultures (Fig. 2D, E) is similar to that of native epithelia
(Fig. 2F) in that there is a variation in the amount of the mucins on
different apical cells, giving the surface a cobblestone pattern of
binding. The intensity of binding of MUC16 is indirectly
correlated to the apical cell surface size in native epithelia
(Fig. 2G)–the cells with the largest surface area having less
MUC16 antibody binding. It has been hypothesized that the
largest cells are the ‘‘oldest cells’’ on the epithelial surface and are
the cells that are about to desquamate in this stratified epithelium
that turns over in 5–7 d [33]. As in native epithelia, the apical cells
of the epithelial cultures form tight junctions, as demonstrated by
binding of antibodies to the tight junction protein occludin along
the lateral membranes of the apical cells (Fig. 2H).
To compare the functions of the mucins in barrier formation,
HCLE cells stably knocked down for either MUC1 or MUC16
[13], using shRNA interference, were used (see Methods Section).
In the shMUC1 knockdown cells, developed for this study, MUC1
protein in cell lysates was significantly reduced, by 71% (p,0.01),
after transfection with two rounds of 1 mg of the psiRNA-H1b-
MUC1 plasmid (InvivoGen) compared to the non-transfected
control (NT) (Fig. 3A). MUC1 protein levels in the control cell
lines with scrambled shRNA for MUC1 (scr1) and MUC16
(scr16), as well as in the cell line knocked down for MUC16
(shMUC16) (Fig. 3A), were not significantly reduced from the non-
transfected control (p,0.01). Most importantly, in addition to the
assay of the level of knockdown of MUC1 in cell lysates, the
amount of the mucin present on the apical membranes of the
stratified, differentiated cultures of HCLE cells was assayed by cell
surface biotin labeling and subsequent capture of labeled MUC1
with immobilized avidin. Western blot analysis of the captured
surface proteins revealed that the MUC1 present on the apical
surface of the HCLE shMUC1 cells (Fig. 3A) was reduced by 60%
compared to non-transfected control cells, and was significantly
lower than all other control cell lines as well as the shMUC16
knockdown cell line (p,0.01) (Fig. 3A).
We have previously reported development of a stable knock-
down of MUC16 in HCLE cells using RNA interference. The
present study used the cells transduced with retrovirus containing
sequence #2 MUC16 shRNA from the earlier report [13], since it
gave the highest knockdown of MUC16 protein after selection
with 2.5-mg/ml puromycin. In this study, MUC16 was knocked
down by 74% in cell lysates compared to the non-transfected
control cell line, and was significantly reduced compared to the
non-transfected control and scrambled shRNA control cell lines as
well as the shMUC1 cell line (p,0.01) (Fig. 3B). Most importantly,
MUC16 on the apical surface of the HCLE shMUC16 (Fig. 3B)
cells was reduced by 51% as compared to non-transfected control,
and was also significantly lower than scrambled shRNA control
cell lines and the shMUC1 cell line (p,0.01) (Fig. 3B). The data
on both knockdown cell lines demonstrate that there was no
significant reduction of surface MUC16 in the HCLE shMUC1
cells, nor was there a reduction of MUC1 on the surface of HCLE
shMUC16 cells (Fig. 3A, B).
Tests of barrier function applied to the HCLE cells with and
without knockdown of either MUC1 or MUC16 included
penetration of rose bengal dye, bacterial adherence, bacterial
invasion, apical tight junction formation and function, and apical
cell surface area. All of these assays demonstrated distinct
differences between the MAMs, MUC16 contributed to mucosal
epithelial barrier function, whereas MUC1 did not.
MUC16, but not MUC1, is a barrier to dye penetrance
Rose bengal is an anionic dye that is frequently used to examine
the integrity of the ocular surface epithelium, as binding of this dye
is indicative of loss of the apical surface barrier [15]. It was
previously shown that differentiated cultures of HCLE cells display
islands of cells that prevent penetrance of rose bengal dye [29] and
that the area of these islands is significantly decreased in the
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used for assay of MUC1 and MUC16 in barrier function. (A)
Epithelial (HCLE) cells stratify in culture when grown for 7 d post
confluence in the presence of serum. Immunoelectronmicroscopy using
gold conjugated secondary antibodies that recognize anti-MUC
antibodies, demonstrates the insertion of both MUC1 (B) and MUC16
(C) on the apical cell membranes of the microplicae of the cultured
epithelial cells. En face images of nonpermeabilized epithelial cells
immunolabeled with FITC conjugated secondary antibodies that bind
to antibodies for MUC1 (D) or MUC16 (E) illustrate that the mucins are
present on apical surfaces of cells, with some cells showing greater
antibody binding than others. This feature mimics that seen in binding
of MUC16 antibodies to apical cells of the native corneal epithelium (F)
(G) Scatter plot of the amount of MUC16 per cell (based on H185
antibody binding intensity) and apical cell surface area illustrates the
inverse correlation of surface amount of MUC16 and cell size. Spearman
Rank Correlation: r=20.36, p,0.0001. Immunolocalization of the tight
junction protein occludin (H) demonstrates the presence of the tight
junctions around the lateral membranes of the apical cells of HCLE
cultures. Scale Bars=20 mm in A, D, E, F, H and 0.2 mmi nB ,C .
doi:10.1371/journal.pone.0100393.g002
Figure 3. Significant knockdown of MUC1 and MUC16 proteins
in both cell lysates and on apical cell surfaces following
transfection with vectors expressing shMUC1 or shMUC16
sequences. (A) Western blots demonstrating that MUC1 protein is
lower in both cell lysates (upper left) and on apical cell surfaces (lower
left) of cell cultures transfected with shMUC1 containing vectors
(shMUC1) compared to the non-transfected control (NT), scrambled
shRNA (scr1) controls, as well as with shMUC16 containing vector
(shMUC16) or its scrambled shRNA control (scr16). Alleles of MUC1
often differ in size and as they are co-dominantly expressed, two
distinct protein sizes are evident on western blots. The graphs to the
right of each blot, show densitometric analyses of bands demonstrating
that MUC1 protein levels are significantly reduced by 71% in the cell
lysates and 60% on apical surfaces relative to NT and scr1 controls and
that MUC1 protein levels are not significantly reduced by knockdown of
MUC16 (shMUC16) or its scrambled shRNA control (scr16). (B) Similarly,
on the left are representative Western blots demonstrating that MUC16
protein levels are lower in cell lysates and biotinylated apical cell surface
protein isolates of cells transfected with shMUC16 containing vectors
compared to non-transfected (NT), or those transfected with scrambled
shRNA for either MUC1 or MUC16 (scr1 and scr16) or shMUC1
containing vectors. The graphs on the right show densitometric
analyses of blots indicating that MUC16 protein levels are significantly
reduced in cell lysates by 70% and on apical surfaces by 51% in cells
transfected with shMUC16 containing vectors in comparison to NT and
scr16 controls. For both (A) and (B) protein samples from cell lysates
Comparison of Mucins MUC1 and MUC16 in Epithelial Barrier Function
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in the HCLE shMUC16 cells used in the present study and the
data, when compared to islands of dye exclusion by shMUC1 and
control cell lines (Fig. 4), were significantly reduced (p,0.01).
Interestingly, the knockdown of MUC1 yielded the opposite result
of the shMUC16 cells (Fig. 4B, F). The area of the islands of cells
within the cultures that prevented dye penetrance was significantly
increased in shMUC1 cells compared to the control cell lines and
shMUC16 cells (p,0.01).
MUC16 is a barrier to bacterial adherence and invasion
It is well established that bacteria do not adhere to or invade the
surface epithelial cells if the glycocalyx forming the apical surface
barrier is intact [14,34,35]. To compare the function of MUC1
and -16 as barriers to pathogen adherence, adherence of
Staphylococcus aureus to apical cells of the cultures of cell lines
knocked down for MUC1 or MUC16, as well as control cell lines,
were examined by two methods after a 1-hour incubation of cells
with bacteria; first by direct visualization and quantitation of
adherent FITC-labeled Staphylococcus aureus (Fig. 5A–F) and second,
by enumerating the number of adherent live bacteria recovered
following plating of epithelial cells on agar plates (Fig. 5G). Both
methods demonstrated that significantly more bacteria adhered to
the shMUC16 cells compared to control and shMUC1 cells.
Interestingly, significantly fewer bacteria adhered to the shMUC1
cells than to the non-transfected control cells (p,0.01), suggesting
that without MUC1, barrier function to pathogen adherence is
improved. The increase of adherence of Staphylococcus aureus after
MUC16 knockdown confirms our previous result with the HCLE
shMUC16 cells [13].
To determine if changes in bacterial adherence translated into
changes in bacterial invasion (a clearer indication of infection), the
incubation of Staphylococcus aureus and epithelial cells was increased
to 4 h, and the number of internalized bacteria was assessed using
an antibiotic protection assay [14,25]. This assay mirrored the
adherence assays (Fig. 5F, G) in that the cells knocked down for
MUC16 had significantly higher invasion of bacteria (p,0.01)
than did the control cell lines and the shMUC1 cells (Fig. 5H).
Similarly the MUC1 knockdown cultures had significantly lower
bacterial invasion than did the control and shMUC16 cultures (p,
0.01), paralleling the bacterial adherence assays (Fig. 5F, G). These
data, as with the dye penetrance studies, demonstrate that
MUC16 contributes to the glycocalyx barrier, whereas loss of
MUC1 improves barrier function, perhaps by providing a more
homogeneous MUC16 coverage to the apical cells.
MUC16 contributes to TER and tight junction formation
We observed that MUC16 knockdown altered the continuity of
Zonula occludens-1 (ZO-1) and occludin localization along lateral
borders of apical cells in the epithelial cultures. In scr16 control
cultures, occludin was present along the apical cell borders in a
linear, undisrupted pattern (Fig. 6A), whereas in the MUC16
knockdown cells, occludin antibody binding was disrupted
(Fig. 6B). Thus, we assessed TER to test tight junction function.
Expression of ZO-1 and occludin RNA was also assayed.
were loaded based on equivalent micrograms of protein, and for cell
surface proteins on equivalent cm
2 of cell growth area. Graphic
representation of the relative amounts of MUC1 (upper right) and
MUC16 (lower right) was derived through densitometric analyses of the
blots, cell lysates were normalized to GAPDH, and all data were
expressed relative to the non-transfected control (NT). Significant if p,
0.01, (**). ns=non-significant, n=5–10.
doi:10.1371/journal.pone.0100393.g003
Figure 4. Knockdown of MUC16 enhances dye penetrance
compared to knockdown of MUC1. Representative images of
cultures of human corneal epithelial cells stably transfected with (A)
scrambled shRNA for MUC1 (scr1), (B) shRNA for MUC1 (shMUC1), (C)
scrambled shRNA for MUC16 (scr16), (D) shRNA for MUC16 (shMUC16)
or the non-transfected control (NT) (E) and then incubated with rose
bengal dye to determine the area of the culture that is protected from
dye penetrance, an indication of a functional apical glycocalyx barrier.
Rose bengal dye is excluded from islands of cells in cultures of non-
transfected (NT) and scrambled shRNA controls (scr1, scr16), as well as
the MUC1 knockdown cells (shMUC1) cultures. Cells knocked down for
MUC16 (shMUC16) do not show as many islands of dye exclusion,
indicating increased penetrance of the dye. (F) Quantitative image
analyses of the area protected from dye penetrance in each cell type
demonstrate a significant decrease in area protected from dye
penetrance in the MUC16 knockdown cells. Conversely, there is a
significant increase in the area protected from dye penetrance in the
MUC1 knockdown (shMUC1) cells. Scale bar=50 mm. **p,0.01, n=8.
doi:10.1371/journal.pone.0100393.g004
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significant change in TER as compared to the control cells, but
knockdown of MUC16 resulted in a highly significant decrease in
TER compared to all other cell lines (Fig. 6C) (p,0.01). Assay of
mRNA in the different cell types revealed no significant change in
ZO-1 or occludin message in the shMUC1 cells compared to the
control cells (Fig. 6D), but a significant decrease in both ZO-1 and
occludin was observed in the shMUC16 cells compared to all
other cells (p,0.01). ZO-1 localization mirrored that seen for
occludin (Fig. 7).
Since the cytoplasmic tail of MUC16 has an ezrin, radixin,
moesin, (ERM) binding domain that allows the ERMs to link to
filamentous actin [13], it is possible that the lack of MUC16 results
in alteration of an apical actin cytoskeleton cortical mat and
terminal web formation, which would influence tight junction
formation [36]. In fact, comparison of non-transfected control and
shMUC16 epithelial cultures double labeled with antibodies to
occludin to delineate tight junctions, and phalloidin to localize
filamentous actin, demonstrates that filamentous actin association
to lateral membranes is disrupted in the shMUC16 cells (Fig. 8A,
B).
MUC16 influences apical membrane surface area
Linkage of membrane-spanning proteins to the actin cytoskel-
eton by members of the ERM family of proteins is known to
regulate development of cell membrane surface projections, in
that, overexpression of the ERMs drives increased length of
microvilli [37,38]. Given that the cytoplasmic tail of MUC16 can
associate with the actin cytoskeleton via its ERM-binding domain
[13] and that MUC1 has been shown in breast cancer cells to
mediate actin cytoskeletal membrane protrusive motility by way of
ICAM-1 ligation and an Src signaling cascade [39], we
hypothesized that MUC1 and MUC16 may, through cytoskeleton
association, induce membrane folds or projections on the epithelial
cells’ apical surface. Lack of such associations could, we
hypothesized, lead to increased apical cell surface area. To test
the hypothesis, lateral cell membranes of the apical cells of
stratified, differentiated cultures of non-transfected and scrambled
shRNA controls, and shMUC1 and shMUC16 cells were
delineated with tight junction markers (ZO-1 and occludin)
(Fig. 7A–7E) and surface area of the apical cells was measured
using the ZO-1 images (Fig. 7F). Measurement of the apical
surface area of the knockdown and control cell types (Fig. 7F)
revealed that the shMUC16 cells had a significantly larger surface
area than did the control and shMUC1 cells (p,0.01). There was
no significant difference in apical cell surface area between the
shMUC1 cells and control cells (Fig. 7F). These in vitro data
showing that MUC16 on apical cells was related to cell surface size
correlated to that shown earlier on native corneal epithelium
(Fig. 2F, G). In native epithelium, there was a highly significant
inverse correlation between the intensity of binding of antibodies
to MUC16 and apical cell surface area. (MUC16: Spearman rank
correlation r value=20.36,; p,0.0001).
Comparison of scanning electron micrographs of the surfaces of
the epithelial cultures of non-transfected controls and shMUC16
cells suggested that fewer microplicae are present on the
shMUC16 cells (Fig. 8C, D). However, as we reported previously
[13], microplicae do occur in the knockdown cells, perhaps due to
remnant MUC16 as surface MUC16 was knocked down by 51%,
other membrane molecules that associate with ERMs to induce
microplicae, and/or artifact due to critical point drying. As in
native epithelium, the larger cells at the surface of the stratified
epithelial cultures, which showed less binding of MUC16
antibodies appeared also to have fewer, more sparsely distributed
microplicae (microridges) (Fig. 8E). Others have noted that fewer
microplicae are present on larger cells at the corneal surface [40].
Diminution in microridges on the surface of the shMUC16 cells
may have resulted in the larger surface areas of both the
Figure 5. Knockdown of MUC16 increases bacterial adherence
and invasion compared to knockdown of MUC1. Three types of
experiments demonstrate that knockdown of MUC16 increases
bacterial adherence and invasion compared to controls, and that
knockdown of MUC1 enhances the barrier to bacterial adherence and
invasion. In the first experiment, epithelial cultures were incubated with
FITC-labeled S. aureus and number of adherent bacteria were counted
in ImageJ. Representative images of S. aureus adherent to cultures are
shown in (A) scrambled MUC1 shRNA control (scr1), (B) MUC1
knockdown (shMUC1), (C) scrambled shMUC16 control (scr16), (D)
MUC16 knockdown (shMUC16) and (E) non-transfected control (NT).
Note abundance of adherent bacteria in the MUC16 knockdown cells in
image D. (F) Graph illustrating the number of FITC-labeled bacteria
adherent to the epithelial cell cultures. Note that knockdown of MUC16
significantly increases adherence of S aureus, whereas knockdown of
MUC1 significantly decreases bacterial adherence. In a second type of
experiment, (G) the differences in bacterial adherence between the
HCLE shMUC1 and HCLEshMUC16 and control cells were corroborated
through enumeration of colony-forming units (cfus) of live bacteria
recovered after the 1-h incubation with S. aureus. In a third experiment,
(H) number of intracellular S. aureus that invaded the cell cultures were
counted after incubation of the cultures for 4 h and determining cfus of
live bacteria recovered from cell lysates following antibiotic treatment
to kill surface bacteria. The three different assays demonstrate that
knockdown of MUC16 is associated with a significant increase in
bacterial adherence and invasion, and that knockdown of MUC1 does
not increase bacterial adherence or invasion, rather the barrier to
bacteria is increased. Scale bar=30 mm. **p,0.01. n=6–8.
doi:10.1371/journal.pone.0100393.g005
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which bound fewer MUC16 antibodies.
These data provide evidence that apical cell surface area
increases when less MUC16 is present on the apical cell surface.
Perhaps, as cells age at the epithelial surface, shedding of the
MUC16 ectodomain, which is known to occur constitutively
in vitro [41] and in vivo [42], causes loss of association to the actin
cytoskeleton and loosening of the lateral adherens and tight
junctions to allow desquamation.
Discussion
Taken together, the data presented herein demonstrate distinct
differences in the contributions of MUC1 and MUC16 to mucosal
epithelial barrier function when present in the same epithelial
apical membrane. Knockdown of MUC16 demonstrated that the
MAM is a barrier to dye penetrance, bacterial adherence and
invasion, is involved in tight junction function and formation, and
apical cell surface area. On the other hand, knockdown of MUC1
showed that this MAM did not contribute to the barrier to dye
penetrance and bacterial adherence nor did it to tight junction
formation and TER, or to cell surface area. Indeed, surprisingly,
for several of these barrier functions, knockdown of MUC1 did just
the opposite–the barrier to dye penetrance and bacterial
adherence and invasion was enhanced in cells with less MUC1.
Perhaps in those epithelia that express these two mucins, MUC16,
through its extraordinary large size, which is approximately 20
times that of MUC1, along with its heavy O-glycosylation,
provides the major barrier. The fact that the loss of MUC1 allows
an even more effective barrier, may be a result of a more
homogeneous MUC16 rich glycocalyx.
The mechanism by which MUC16 provides an especially robust
barrier may be due, not only to its exceptional ectodomain length
of approximately 22,000 amino acids, which has been estimated to
extend 250–300 nm from the cell surface [43] but also to its N-
terminal half, which is heavily O-glycosylated. Inhibition of
MUC16 O-glycosylation by knockdown of T-synthase, a galacto-
syltransferase required for synthesis of core1 O-glycans, resulted in
decreased surface O-glycosylation and increased dye penetrance,
indicating the importance of O-glycan in barrier function of the
MAM [15]. Furthermore, the multivalent carbohydrate binding
lectin galectin 3 binds to the glycans of MUC16 (as well as
MUC1), and disruption of the galectin 3-O-glycan interaction with
competitive carbohydrate inhibitors results in dye penetrance, and
abrogation of barrier function [15]. Thus, the molecular
mechanism of MAM barrier function is that of extended, heavily
glycosylated MAM ectodomains, linked to one another through
multimeric galectins. A longer molecule, such as MUC16, would
provide more surface for glycan-galectin interactions to hold the
molecules in a tight barrier conformation. In a glycocalyx in which
the MAM repertoire is mixed, several levels of MAM-galectin
association may be present with MUC16 ectodomains extending
further from the cell membrane than MUC1. This could provide
an uneven, mixed-length extension of the MAMs in the
glycocalyx, thus providing differences in length that pathogens
Figure 6. Knockdown of MUC16 results in decreased tight junction function and ZO-1/occludin expression, whereas knockdown of
MUC1 has no effect on tight junctions. (A) Immunofluorescence analysis of occludin localization demonstrated normal linear distribution of
occludin in the MUC16 scrambled control (scr16) cells (A) as compared to the disrupted localization seen in the shMUC16 cells (B). (C) A highly
significant decrease in transepithelial electrical resistance (TER) was observed in the MUC16 knockdown (shMUC16) cell cultures compared to control
cultures and shMUC1 cultures. No difference was seen in TER in the MUC1 knockdown (shMUC1) cells n=15–30. (D) Analysis of the relative mRNA
expression of two tight junction genes (ZO-1, occludin) by qPCR demonstrated a significant reduction in their message in the shMUC16 cells
compared to the non-transfected (NT), or scrambled shRNA controls (scr1, scr16) and shMUC1 cells. n=7, **p,0.01, ns=not significant.
doi:10.1371/journal.pone.0100393.g006
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expression levels of MUC1 with its shorter ectodomain, leaves a
more uniform MUC16, glycan-rich, uniform barrier with a more
robust barrier function.
The data indicating that decrease in expression of MUC1
enhances barrier function in the corneal epithelium seems to
contradict the studies cited in the introduction to this manuscript
that demonstrate that MUC1 prevents pathogen adherence and
penetrance. While our study demonstrates a greater role for
MUC16 in barrier function, it does not eliminate the possibility
that MUC1 has a barrier role in other epithelia, especially in those
epithelia that do not express the very large mucin MUC16. The
data do suggest, however, that barrier functions of each of the
MAMs expressed by a mucosal epithelium may need to be
evaluated in the context of the MAM repertoire of that epithelium.
In fact, in a study of the role of MUC1 in adenoviral access to the
respiratory epithelium, the authors state that ‘‘the inability to
achieve high gene transfer efficiency, even in mice with a depletion
of Muc1, suggested that other glycocalyx components, possibly
other tethered mucin types, also provide significant barrier to
AdV’’[9].
It would be ideal to verify the data on the functions of the
human mucins MUC1 and MUC16, provided herein, in mice null
for the human homologues designated Muc1 or Muc16. Indeed
such animals have been produced [11,44,45]. There are however
major differences in the structures of the human and mouse
MAMs, particularly in their ectodomains sizes and homologies.
The ectodomain of human MUC1 is 1140 AA’s whereas in the
mouse homologue, it is approximately 550 AA’s. The C terminal
cytoplasmic tail region of the MUC1 homologues is 72 AA and is
the most homologous region of the molecule. Similarly, the
ectodomain of human MUC16, is approximately 22,110 AA’s,
whereas the mouse Muc16 is much smaller at approximately 8,830
AA’s. As with MUC1 the cytoplasmic tail sequence of MUC16 is
conserved between species and is 35AA’s in length. Most
importantly however, in terms of comparing the functions of the
two mucins, the mucosal epithelial expression pattern of MUC16
is very different between the two species. In human’s MUC16 is
expressed in corneal and uterine epithelial surfaces whereas in
mice it is not [11]. These differences, plus variations in mucin
glycosylation characteristics that exist between species, make
comparisons between specific mucin functions across the two
species difficult.
To our knowledge the only other study in which the
comparative barrier function of two MAMs has been tested has
been in the role of MUC16 in trophoblast adherence in the human
endometrium [5]. Data from that study agree with that of the
present study in that MUC16 was shown to be a barrier to
trophoblast cell adherence, whereas MUC1 was not. These studies
initiated from the demonstration that MUC16 was dramatically
shed from the apical glycocalyx of endometrial epithelium, 5–7
days after LH surge, the time of trophoblast adherence to the
endometrium, which initiates implantation. Immunohistochemical
analysis of the endometrial surface indicated that both MUC1 and
MUC16 are expressed by the endometrium. MUC1 was not,
however, shed from the ciliated cells at LH 5–7. MUC16 and
MUC1 were independently and stably knocked down in an
endometrial cell line using shRNA methods and then tested for
adherence of cells from a trophoblast cell line. Trophoblast cells
adhered in greater numbers to the cells knocked down for
MUC16, whereas knockdown of MUC1 did not affect adherence.
In addition to its expression by the corneal epithelium, the large
MUC16 MAM is expressed by tracheal-bronchial epithelia, and
endometrial and cervical epithelia [5,44,46,47].
All these epithelia, except for the corneal epithelium, express
MUC4 in addition to MUC1 and MUC16, but like MUC1,
MUC4 is a much smaller mucin than MUC16. Perhaps the
mucosal epithelia where MUC16 is expressed, need an especially
Figure 7. Knockdown of MUC16 results in an increase in apical
cell surface area compared to knockdown of MUC1. Cell
perimeters were labeled with antibodies to occludin followed by
labeling with FITC conjugated secondary antibodies (A–E). Note the
disruptions in the linear localization around the cell peripheries in the
MUC16 knockdown cells, shMUC16 (D) compared to the continuous
linear localization in the scrambled shRNA controls scr1 (A), scr16 (C)
and non-transfected NT (E) controls as well as the MUC1 knockdown
shMUC1 cells (B). (F) Measurement of apical cell surface area in the ZO-1
labeled cultures revealed that the mean apical surface area of the
shMUC16 cells is significantly larger than those of the NT, scr1, scr16
and shMUC1 cells, all of which have comparable apical cell surface
areas. Scale bar=30 mm. **p,0.01, ns=not significant, n=7, 5 images/
sample.
doi:10.1371/journal.pone.0100393.g007
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adherence. The ocular surface and respiratory epithelia are
directly exposed to environmental particulates and pathogens
and, thus, require an exceptionally efficient and robust barrier.
The female endometrial and cervical epithelia need a surface that
will prevent pathogen and cell-cell adherence, particularly in
relation to sperm and unfertilized ova. The gastrointestinal
epithelial surfaces, although exposed to large numbers of bacteria,
do not express the large MUC16. Goblet cells within these
epithelia do however secrete large amounts of mucins in which
pathogens are trapped, and upon which pathogens feed.
A surprising finding of this study was that knockdown of
MUC16, but not MUC1, disrupted tight junction formation and
resultant tight junction function as measured by TER. The
knockdown also showed downregulation of ZO-1 and occludin
expression, and apical cells of the stratified cell cultures show
larger apical surface area (Figs. 6 and 7). MUC16 has a polybasic
juxtamembrane amino acid domain, RRRKK, in its cytoplasmic
tail sequence, and we have shown previously, that synthetic
peptides mimicking the MUC16 CT, bind the actin cytoskeleton
linker moesin, a member of the ezrin-radixin-moesin (ERM)
family of proteins [13]. MUC1 has an RRK sequence near the
transmembrane domain; however, peptides mimicking the MUC1
cytoplasmic tail domain, do not, in our hands, bind ERM proteins.
These data indicate that the MUC16 cytoplasmic tail can, through
ERM binding, link the cytoplasmic tail of MUC16 to filamentous
actin. ERMs, by linking membrane-tethered proteins to filamen-
tous actin are known to be involved in development and
lengthening of cell surface membrane protrusions such as
microvilli. They are also known to influence adherence junction
formation (for review see [48]). Perhaps knockdown of MUC16
and, thus, loss of cytoplasmic tail association to ERM’s in apical
membranes of corneal epithelia, results in the lack of association of
the membrane to the actin filaments that insert into surface
microplicae (microridges) (Fig. 1A) and to the apical actin network
involved in cell surface membrane organization, leading to the
increase in cell surface area demonstrated in Figure 7. Concom-
itantly, the apical cortical web of actin filaments may not form,
leading to the disrupted adherence and tight junction formation
(for review of the linkage of adherens and tight junction formation
see [36]) and, thus, the lowered TER observed in this study. The
data showing the role of MUC16 in tight junction formation
suggests an important role for the MUC16 cytoplasmic tail in
maintenance of epithelial barrier function through anchorage of
MUC16 in its position at the apical surface to the actin
cytoskeleton. To our knowledge this is the first demonstration of
the association of a MAM with tight junction formation.
The question arises, could the disruption of tight junctions
rather than loss of the MUC16 ectodomain in the MUC16
knockdown cells be responsible for the increase in dye penetrance
Figure 8. Knockdown of MUC16 results in disruption of the actin cytoskeleton associated with tight junctions and reduces surface
microplicae. Epithelial cultures of non-transfected controls (A) and those transfected with shMUC16 (B) were double labeled with an antibody to
occludin (green) and Phalloidin (red) to localize filamentous actin; note the actin filaments associated with the linear occludin antibody binding in A,
and the lack of filamentous actin along the disrupted occludin antibody binding in B. Scanning electron micrographs of control epithelial cultures (C),
shMUC16 cultures (D) and native epithelium (E). Note fewer prominent microplicae in the cells knocked down for MUC16 in D and also in the larger
darker cell of native epithelium (E), that were shown (Fig. 2F) to bind less antibody to MUC16. The larger darker cells show fewer microplicae than
neighboring smaller light cells. Scale bars=15 mmi nA ,B ,1 0mmi nC ,D ,5mmi nE .
doi:10.1371/journal.pone.0100393.g008
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previous data indicate that the ectodomain is acting as the barrier
to dye penetrance and bacterial adherence. First of all, rose bengal
dye will cross the cell membrane into cells that lack a mucin
surface and that have no associated tight junctions. For instance,
rose bengal penetrates fibroblasts in culture, whereas those
stratified epithelia expressing apical mucins, develop a barrier to
dye penetrance [29]. The dye also penetrates epithelial cells in
cultures that have not been induced to stratify and produce apical
surface mucins, i.e., pre-confluent and confluent but not stratified
cultures [13]. The dye also penetrates epithelial cells in which O-
glycosylation has been molecularly blocked, but in which MUC16
is expressed. The paper describing that data, also demonstrates
quite conclusively that the tight junctions and transepithelial
resistance are not altered by the deglycosylation [15]. Finally,
enzymatic release of the MUC16 ectodomain by Streptoccus
pneumoniae derived zinc metalloprotease C, which also does not
alter tight junctions, also increases rose bengal dye penetrance
[14]. Taken together, this body of data indicate that the rose
bengal dye penetrance is through apical membranes into the
cytoplasm of cells that lack the MUC16 ectodomain or in which its
glycosylation has been altered. A similar result was obtained
regarding the role of the MUC16 ectodomain in bacterial
adherence and invasion. In previous work we demonstrated that
enzymatic removal of the ectodomain of MUC16 by Streptococcus
pneumoniae derived zinc metalloproteinase C, caused, in addition to
increased rose bengal dye penetrance, increased bacterial adher-
ence and penetrance [14]. We found no loss of tight junctions or
decrease in transepithelial resistance with this treatment.
All the studies reported herein show no function for MUC1 in
the barrier parameters tested. If MUC1 does not contribute to the
barrier functions at the surface of epithelia in which MUC16 is
expressed, what is the function of the molecule? It appears clear
from a series of studies, particularly in cancer cells, that the MUC1
CT participates in signaling pathways (for review see [2]). As an
example, MUC1 has an EGF-like domain near the transmem-
brane domain, and binding of EGF receptors has been shown to
phosphorylate tyrosine residues in its short cytoplasmic tail [26]. It
is not clear if this activity occurs in native epithelia. Other studies
have demonstrated a role for MUC1 in native immunity. For
example in respiratory epithelia, MUC1 negatively regulates TLR
signaling in response to infection and inflammation [49]. These
non-barrier functions ascribed to MUC1 indicate the ‘‘multifunc-
tional’’ properties sometimes ascribed to the mucin [2]. Perhaps
when MUC1 is present on epithelia on which larger membrane
mucins such as MUC16 are present, its function as a barrier is
diminished, but its signaling activity in response to the external
environment remains.
In summary, when barrier functions of the membrane-anchored
mucins MUC1 and MUC16 are tested within the same epithelial
type, MUC16, with its much larger ectodomain and actin-
associated cytoplasmic tail, is the predominant contributor to the
barrier against pathogen adherence/penetrance and dye pene-
trance, and it participates in tight junction formation.
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